A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns
- PMID: 39231505
- PMCID: PMC11704856
- DOI: 10.3947/ic.2024.0070
A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns
Abstract
Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.
Keywords: HPV vaccine; Human papillomavirus; Vaccine ethics; Vaccine hesitancy; Vaccine safety.
© 2024 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, The Korean Society for AIDS, and Korean Society of Pediatric Infectious Diseases.
Conflict of interest statement
No conflict of interest.
Comment in
-
Response to "A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns".Infect Chemother. 2025 Sep 10. doi: 10.3947/ic.2024.0113. Online ahead of print. Infect Chemother. 2025. PMID: 40958491 No abstract available.
References
-
- Human papillomavirus vaccination. Committee Opinion No. 704. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;129:e173–e178.
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Beavis AL, Gravitt PE, Rositch AF. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer. 2017;123:1044–1050. - PubMed
-
- Petrosky E, Bocchini JA, Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE Centers for Disease Control and Prevention (CDC) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–304. - PMC - PubMed
-
- Tomljenovic L, Shaw CA. Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil. J Law Med Ethics. 2012;40:673–681. - PubMed